Exhibit 5.1
Fred S. Skolnik
Partner
Direct Dial 516.296.7048
fskolnik@certilmanbalin.com
October 6, 2025
BioRestorative Therapies, Inc.
40 Marcus Drive
Suite One
Melville, New York 11747
Ladies and Gentlemen:
We have acted as counsel to BioRestorative Therapies, Inc., a Nevada corporation (the “Company”), in connection with the Registration Statement on Form S-3 (File No. 333-269631) (the “Registration Statement”) filed with the Securities and Exchange Commission (the “Commission”) pursuant to the Securities Act of 1933, as amended (the “Securities Act”), and the rules and regulations thereunder (the “Rules”), which became effective on February 14, 2023. You have asked us to furnish our opinion as to the legality of the 678,125 shares of common stock of the Company, par value $0.0001 per share (the “Shares”), which are registered under the Registration Statement and which are to be issued and sold by the Company pursuant to the Subscription Agreements, dated as of October 6, 2025, by and between the Company and the purchasers signatory thereto (the “Subscription Agreements”).
In connection with the furnishing of this opinion, we have examined originals, or copies certified or otherwise identified to our satisfaction, of the following documents:
| 1. | the Registration Statement; | |
| 2. | the prospectus supplement dated October 6, 2025 (the “Prospectus”); and | |
| 3. | the Subscription Agreements. |
In addition, we have examined (i) such corporate records of the Company as we have considered appropriate, including a copy of the amended and restated articles of incorporation and by-laws of the Company and copies of resolutions of the board of directors of the Company relating to the issuance of the Shares, and (ii) such other certificates, agreements and documents as we deemed relevant and necessary as a basis for the opinions expressed below. We have also relied upon the factual matters contained in the representations and warranties of the Company made in the documents reviewed by us and upon certificates of public officials and the officers of the Company.
October 6, 2025
Page 2
In our examination of the documents referred to above, we have assumed, without independent investigation, the genuineness of all signatures, the legal capacity of all individuals who have executed any of the documents reviewed by us, the authenticity of all documents submitted to us as originals, the conformity to the originals of all documents submitted to us as certified, photostatic, reproduced or conformed copies of valid existing agreements or other documents, the authenticity of all such latter documents and that the statements regarding matters of fact in the certificates, records, agreements, instruments and documents that we have examined are accurate and complete.
Based upon the above, and subject to the stated assumptions, exceptions and qualifications, we are of the opinion that the Shares have been duly authorized by all necessary corporate action on the part of the Company and, when issued, delivered and paid for as contemplated in the Registration Statement and in accordance with the terms of the Subscription Agreements, the Shares will be validly issued, fully paid and non-assessable.
The opinion expressed above is limited to the Nevada Revised Statutes. Our opinion is rendered only with respect to the laws, and the rules, regulations and orders under those laws, that are currently in effect.
We hereby consent to the use of this opinion as an exhibit to the Company’s Current Report on Form 8-K filed by the Company with the Commission on the date hereof, and to the use of our name under the heading “Legal Matters” contained in the base prospectus included in the Registration Statement and in the Prospectus Supplement. In giving this consent, we do not thereby admit that we come within the category of persons whose consent is required by the Securities Act or the Rules.
| Sincerely, | ||
| CERTILMAN BALIN ADLER & HYMAN, LLP | ||
| By: | /s/ Fred Skolnik | |
| Fred Skolnik, a member of the Firm | ||